Stock Events

Stock Events

Teva- Pharmaceutical Industries 

€34.80
672
+€0.00+0%Friday 12:49

Statistics

Day High
34.8
Day Low
34.6
52W High
35.4
52W Low
34.2
Volume
0
Avg. Volume
0
Mkt Cap
40.59B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 2017
€0.07
Sep 2017
€0.07
Jun 2017
€0.30
Mar 2017
€0.32
Dec 2016
€0.33
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Feb 10Expected
Q2 2026
Q3 2026
Next
0.02
0.27
0.52
0.77
Expected EPS
0.6012912038
Actual EPS
N/A

Financials

8.12%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
14.97BRevenue
1.22BNet Income

Analyst Ratings

$38.13Average Price Target
The highest estimate is ⁦43.25⁩.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TEVA.STU. It's not an investment recommendation.
NVIDIA
118
NVDA
Amazon
111
AMZN
Microsoft
106
MSFT
Apple
104
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap303.67B
Novartis, through its Sandoz division, is a leading competitor in the generic pharmaceuticals market, directly challenging Teva's product lineup.
Pfizer
PFE
Mkt Cap173.95B
Pfizer, with its Upjohn division now merged into Viatris, competes in both the generic and branded pharmaceutical markets, overlapping with Teva's business areas.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes with Teva in the specialty pharmaceutical sector, particularly in areas like biosimilars and branded pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the branded pharmaceutical market, particularly in areas where Teva also operates.
Merck
MRK
Mkt Cap368.89B
Merck competes with Teva in the development and marketing of branded pharmaceuticals, especially in therapeutic areas where Teva is active.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences competes with Teva in the specialty pharmaceuticals market, particularly in the antiviral sector where Teva also has a presence.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes with Teva in the biopharmaceutical sector, particularly in the development of biosimilars, a growing area of Teva's business.
Sanofi
SNY
Mkt Cap106.24B
Sanofi competes with Teva in both the branded and generic pharmaceutical markets, with a broad product portfolio that overlaps with Teva's.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca competes with Teva in the branded pharmaceutical sector, particularly in areas like respiratory and cardiovascular diseases where Teva is also active.

About

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Show More
CEO
Richard D. Francis
Employees
32842
Country
Israel
ISIN
IL0006290147
WKN
000906517

Listings

XNYS
US
TEVA
SA
BR
T1EV34.SA
TA
IL
TEVA.TA
F
DE
TEVA.F

0 Comments

Share your thoughts

FAQs

What is Teva- Pharmaceutical Industries stock price today?▼
The current price of TEVA.STU is €34.80 EUR — it has increased by +0% in the past 24 hours. Watch Teva- Pharmaceutical Industries stock price performance more closely on the chart.
What is Teva- Pharmaceutical Industries stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Teva- Pharmaceutical Industries stocks are traded under the ticker TEVA.STU.
What is Teva- Pharmaceutical Industries market cap?▼
Today Teva- Pharmaceutical Industries has the market capitalization of 40.59B
When is the next Teva- Pharmaceutical Industries earnings date?▼
Teva- Pharmaceutical Industries is going to release the next earnings report on February 10, 2027.
What were Teva- Pharmaceutical Industries earnings last quarter?▼
TEVA.STU earnings for the last quarter are 0.77 EUR per share, whereas the estimation was 0.64 EUR resulting in a +19.31% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Teva- Pharmaceutical Industries revenue for the last year?▼
Teva- Pharmaceutical Industries revenue for the last year amounts to 14.97B EUR.
What is Teva- Pharmaceutical Industries net income for the last year?▼
TEVA.STU net income for the last year is 1.22B EUR.
Does Teva- Pharmaceutical Industries pay dividends?▼
Yes, TEVA.STU dividends are paid quarterly. The last dividend per share was 0.07 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Teva- Pharmaceutical Industries have?▼
As of November 7, 2026, the company has 32,842 employees.
In which sector is Teva- Pharmaceutical Industries located?▼
Teva- Pharmaceutical Industries operates in the Health & Wellness sector.
When did Teva- Pharmaceutical Industries complete a stock split?▼
The last stock split for Teva- Pharmaceutical Industries was on July 1, 2004 with a ratio of 2:1.
Where is Teva- Pharmaceutical Industries headquartered?▼
Teva- Pharmaceutical Industries is headquartered in TEL AVIV, Israel.